Barja-Ore J, Valverde-Espinoza N, Campomanes-Pelaez E, Alaya RN, Sánchez GE, Silva RJ, Zuñiga-Olivera N

Language: Spanish
References: 22
Page:
PDF size: 217.02 Kb.

ABSTRACT

Introduction: COVID-19 in pregnant women has been a challenge in maternal care, since it could increase the risk of suffering from some obstetric diseases and negative perinatal results.
Objective: To describe the epidemiological characteristics and obstetric complications in pregnant women diagnosed with COVID-19.
Methods: Descriptive, and cross-sectional study, carried out in a sample of 235 pregnant women with a diagnosis of COVID-19, selected in a non-random way. Epidemiological characteristics and obstetric complications were studied, which were reported by descriptive statistics in univariate tables.
Results: The average age of the pregnant women was 27.6 ± 3.7 years, 65.5 % were cohabiting and 77.4 % had secondary education. In addition, 71.5 % were between 37 and 40 weeks' gestation, 28.5 % had no prenatal care, 68.9 % were multi-pregnant, and 27.7 % had a history of abortion; 90.6 % were asymptomatic and headache was the most frequent symptom (7.4 %). Among obstetric complications, 30.6 % had a cesarean birth, 20 % had anemia and 15.7 % premature rupture of the membrane. Hellp syndrome (0.9 %) and eclampsia (0.4 %) were the least frequent.
Conclusions: In pregnant women with COVID-19 there is a high rate of obstetric complications, which are mainly caesarean section and anemia. Most pregnant women are asymptomatic and have an IgM / IgG serological result.

REFERENCES

1. Cruz S, De la Cruz ML, Carmona P, Abascal-Saiz A, Pintando P, González L, et al. Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study. Viruses. 2021 [acceso: 28/07/2021]; 13(5): 853. Disponible en: https://doi.org/10.3390/v13050853

2. Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, iao AH. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol. 2020 [acceso: 27/07/2021]; 84(5): e13304. Disponible en: https://doi.org/10.1111/aji.13304

3. Wastnedge E, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021[acceso: 27/07/2021]; 101(1): 303-318. Disponible en: https://doi.org/10.1152/physrev.00024.2020d

4. Haizler-Cohen L, Davidov A, Blitz MJ, Fruhman G. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units. Am J Obstet Gynecol. 2021[acceso: 27/07/2021]; 224(1): 112-14. Disponible en: https://doi.org/10.1016/j.ajog.2020.09.022

5. Savirón-Cornudella R, Villalba A, Zapardiel J, Andeyro-Garcia M, Esteban LM, Pérez-López FR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery. Eur J Obstet Gynecol Reprod Biol. 2021 [acceso: 28/07/2021]; 256: 400-4. Disponible en: https://doi.org/10.1016/j.ejogrb.2020.11.069

6. Organización Panamericana de la Salud / Organización Mundial de la Salud. Actualización epidemiológica: Enfermedad por Coronavirus (COVID-19). 22 de julio de 2021, Washington, D.C.: OPS/OMS; 2021 [acceso: 29/07/2021]. Disponible en: Disponible en: https://www.paho.org/es/file/92055/download?token=3nPUqnh4

7. Vera E, Montenegro I, Marcelo H, Arce M, Cruzate V, Pelaez M. Gestación en tiempos de pandemia COVID 19. Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Perú. Rev Peru Ginecol Obstet. 2020 [acceso: 24/06/2021]; 66(3): [aprox. 5 pant.]. Disponible en: https://doi.org/10.31403/rpgo.v66i2265

8. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021 [acceso: 26/06/2021];193(16): E540-E548. Disponible en: https://doi.org/10.1503/cmaj.202604

9. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020 [acceso: 26/06/2021];25(1):39. Disponible en: https://doi.org/10.1186/s40001-020-00439-w

10. Marín MA, Reyne M, Caserío S, Sole L, Carrizosa T, Rivero I, et al. Maternal, Perinatal and Neonatal Outcomes With COVID-19: A Multicenter Study of 242 Pregnancies and Their 248 Infant Newborns During Their First Month of Life. Pediatr Infect Dis J. 2020 [acceso: 15/07/2021]; 39(12): e393-e397. Disponible en: https://doi.org/10.1097/INF.0000000000002902

11. Di Guardo F, Di Grazia FM, Di Gregorio LM, Zambrotta E, Carrara G, Gulino FA, et al. Poor maternal-neonatal outcomes in pregnant patients with confirmed SARS-Cov-2 infection: analysis of 145 cases. Arch Gynecol Obstet. 2021 [acceso: 20/07/2021]; 303: 1483-1488. Disponible en: https://doi.org/10.1007/s00404-020-05909-4

12. Huerta IH, Elías JC, Campos K, Muñoz R, Coronado JC. Características materno perinatales de gestantes COVID-19 en un hospital nacional de Lima, Perú. Rev Peru Ginecol Obstet. 2020[acceso: 25/07/2021]; 66(2): 00003. Disponible en: http://dx.doi.org/10.31403/rpgo.v66i2245

13. Timircan M, Bratosin F, Vidican I, Suciu O, Tirnea L, Avram V, et al. Exploring Pregnancy Outcomes Associated with SARS-CoV-2 Infection. Medicina. 2021 [acceso; 10/07/2021]; 57: 796. Disponible en: https://doi.org/10.3390/medicina57080796

14. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021 [acceso: 30/07/2021]; 175(8):817-826. Disponible en: https://doi.org/10.1001/jamapediatrics.2021.1050

15. Dávila-Aliaga C, Hinojosa-Pérez R, Espinola-Sánchez M, Torres-Marcos E, Guevara-Ríos E, Espinoza-Vivas Y, et al. Resultados materno-perinatales en gestantes con COVID-19 en un hospital nivel III del Perú. Rev Peru Med Exp Salud Publica. 2021 [acceso: 30/07/2021]; 38(1):58-63. Disponible en: https://doi.org/10.17843/rpmesp.2021.381.6358

16. Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021[acceso: 25/07/2021]; 225(3): 289. e1-289.e17. Disponible en: https://doi.org/10.1016/j.ajog.2021.05.014

17. Singh V, Choudhary A, Datta MR, Ray A. Maternal and Neonatal Outcomes of COVID-19 in Pregnancy: A Single-Centre Observational Study. Cureus. 2021 [acceso: 26/07/2021]; 13(2):e13184. Disponible en: https://doi.org/10.7759/cureus.13184

18. Yang R, Mei H, Zheng T, Fu Q, Zhang Y, Buka S, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med. 2020 [acceso: 17/07/2021]; 18:330. Disponible en: https://doi.org/10.1186/s12916-020-01798-1

19. Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020 [acceso: 04/08/2021]; 127(12):1548-56. Disponible en: https://doi.org/10.1111/1471-0528.16403

20. Zlochiver V, Tilkens B, Perez AC, Aziz F, Jan MF. COVID-19 Deliveries: Maternal Features and Neonatal Outcomes. J Patient Cent Res Rev. 2021 [acceso: 04/08/2021]; 8(3):286-289. https://doi.org/10.17294/2330-0698.1848

21. Mullins E, Hudak ML, Banerjee J, Getzlaff T, Townson J, Barnette K, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021 [acceso: 05/08/2021]; 57(4):573-581. Disponible en: https://doi.org/10.1002/uog.23619

22. Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PloS One. 2021 [acceso: 05/08/2021]; 16(5):e0251123. Disponible en: https://doi.org/10.1371/journal.pone.0251123